131 related articles for article (PubMed ID: 19593614)
1. Significance of volume-reduction surgery for far-advanced gastric cancer during treatment with novel anticancer agents.
Yamamoto Y; Yoshikawa T; Morinaga S; Kasahara A; Yoneyama K; Osaragi T; Matsuura H; Yoshida T; Hasegawa S
Int J Clin Oncol; 2009 Jun; 14(3):225-9. PubMed ID: 19593614
[TBL] [Abstract][Full Text] [Related]
2. Surgery after preoperative chemotherapy for patients with unresectable advanced gastric cancer.
Yamamoto M; Sakaguchi Y; Matsuyama A; Yoshinaga K; Tsutsui S; Ishida T
Oncology; 2013; 85(4):241-7. PubMed ID: 24107642
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Conversion Surgery Following First- or Second-line Chemotherapy for Unresectable Gastric Cancer.
Fukuchi M; Mochiki E; Ishiguro T; Kumagai Y; Ishibashi K; Ishida H
Anticancer Res; 2018 Nov; 38(11):6473-6478. PubMed ID: 30396974
[TBL] [Abstract][Full Text] [Related]
4. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
Ohnuma H; Sato Y; Onoyama N; Hamaguchi K; Hayasaka N; Sato M; Murase K; Takada K; Miyanishi K; Murakami T; Ito T; Nobuoka T; Takemasa I; Kato J
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2385-2396. PubMed ID: 33534051
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective analysis of generalized chemotherapy for unresectable advanced gastric cancer].
Miura T; Nakamura J; Yamada S; Nakazawa Y; Ozeki Y; Miura T; Yanagi M; Takahashi T
Gan To Kagaku Ryoho; 2010 Jan; 37(1):77-81. PubMed ID: 20087036
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
8. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
Sato Y; Ohnuma H; Nobuoka T; Hirakawa M; Sagawa T; Fujikawa K; Takahashi Y; Shinya M; Katsuki S; Takahashi M; Maeda M; Okagawa Y; Naoki U; Kikuch S; Okamoto K; Miyamoto H; Shimada M; Takemasa I; Kato J; Takayama T
Gastric Cancer; 2017 May; 20(3):517-526. PubMed ID: 27553665
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
12. [Conversion Surgery following Second-Line Chemotherapy for Unresectable Gastric Cancer].
Ishiguro T; Mochiki E; Ito T; Ishikawa H; Yamamoto E; Sato T; Chikatani K; Yamamoto A; Chika N; Toyomasu Y; Hatano S; Kumagai Y; Ishibashi K; Maki A; Ishida H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1828-1830. PubMed ID: 35046344
[TBL] [Abstract][Full Text] [Related]
13. Postoperative chemotherapy for gastric cancer in the elderly.
Maehara Y; Yamamoto M; Endo K; Baba H; Kusumoto H; Sugimachi K
Chemotherapy; 1994; 40(4):279-86. PubMed ID: 8082416
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
[TBL] [Abstract][Full Text] [Related]
15. Postoperative chemotherapy for patients with advanced gastric cancer.
Maehara Y; Emi Y; Moriguchi S; Takahashi I; Yoshida M; Kusumoto H; Sugimachi K
Am J Surg; 1992 Jun; 163(6):577-80. PubMed ID: 1595836
[TBL] [Abstract][Full Text] [Related]
16. The long-term survival of stage IV gastric cancer patients with conversion therapy.
Yamaguchi K; Yoshida K; Tanahashi T; Takahashi T; Matsuhashi N; Tanaka Y; Tanabe K; Ohdan H
Gastric Cancer; 2018 Mar; 21(2):315-323. PubMed ID: 28616743
[TBL] [Abstract][Full Text] [Related]
17. Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer.
Chen GM; Yuan SQ; Nie RC; Luo TQ; Jiang KM; Liang CC; Li YF; Zhang DY; Yu JH; Hou F; Wang Y; Chen YB
Ann Surg Oncol; 2020 Oct; 27(11):4250-4260. PubMed ID: 32506192
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of postoperative adjuvant chemotherapy using S-1 plus CDDP for type 4 gastric cancer].
Asaumi Y; Miyanaga T; Hosokawa O; Nishida Y; Matsunaga T; Shimizu S; Tanaka N; Ito T; Sato Y; Hirano Y; Maeda K; Ota K; Doden K; Hattori M; Hashizume Y
Gan To Kagaku Ryoho; 2013 Mar; 40(3):323-5. PubMed ID: 23507592
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy in adjuvant chemotherapy regimens in patients with radically resected gastric cancer : a propensity-matched analysis.
Quan R; Huang J; Chen H; Liao Y; Lv W; Chen N; Liu J; Zhang H; Xu D
Oncotarget; 2016 Nov; 7(46):76316-76326. PubMed ID: 27602756
[TBL] [Abstract][Full Text] [Related]
20. Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
Maehara Y; Sugimachi K; Akagi M; Kakegawa T; Shimazu H; Tomita M
Br J Cancer; 1992 Mar; 65(3):413-6. PubMed ID: 1558796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
